Fortress Biotech Inc reports results for the quarter ended in March - Earnings Summary

Fortress Biotech

15/05/2024 22:39

* Fortress Biotech Inc  FBIO.OQ  reported a quarterly
adjusted
loss of $1.03​​ per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of $-3.15.  The mean expectation of three analysts for the
quarter was for a loss of $1.73 per share. Wall Street expected
results to range from $-2.60 to $-1.13 per share.
    * Revenue rose 4.8% to $13.03 million from a year ago;
analysts
expected $14.13 million. 
    * Fortress Biotech Inc's reported EPS for the quarter was a
loss
of $1.03​.
    * The company reported a quarterly loss of $15.42 million.
    * Fortress Biotech Inc shares had fallen by 12.0% this
quarter and
lost 41.5% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Fortress Biotech
Inc is $24.00 
This summary was machine generated from LSEG data May 15 at
09:38 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.73          -1.03          Beat
 Dec. 31 2023      -1.97          -1.28          Beat
 Sep. 30 2023      -3.21          -0.94          Beat
 Jun. 30 2023      -3.41          -3.60          Missed